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ABSTRACT
The hematopoietic compartment is tasked with the establishment and maintenance
of the entire blood program. Key to this process are hematopoietic stem cells (HSCs),
which possess the unique ability to self-renew and differentiate to replenish blood cells
throughout an organism’s lifetime. In a screen for epigenetic regulators of hematopoiesis
in zebrafish, we identified chromatin remodeling protein and transcription repressor, Ing4,
as a requirement for hematopoietic stem and progenitor cell (HSPC) specification. Ing4, a
member of the inhibitor of growth (ING) family, is a subunit of the HB01-JADE-hEAF6
histone acetyltransferase complex responsible for most nucleosomal histone H4 acetylation
in eukaryotes. Ing4 is known to form an inhibitory complex with RelA, the large subunit
of the NF-kB protein complex, limiting expression of NF-kB target genes. NF-kB is a
dimeric complex of Rel proteins that can activate, and sometimes repress transcription of
cytokine genes. Thus, loss of Ing4 in mice causes hyper inflammatory responses because
there is no inhibition of NF-kB. Ing4 has also been suggested to regulate a wide variety of
cellular processes, including DNA repair, apoptosis, cell-cycle regulation, metastasis,
angiogenesis, and tumor suppression. The role of Ing4 in hematopoiesis has not been
established.
Here, we present data that shows Ing4 is critical for HSC gene regulation to direct
both stem cell maintenance and differentiation in mice. Utilizing competitive
transplantation, flow cytometry analysis of Ing4-deficient mouse bone marrow and
peripheral blood, as well as colony-forming unit (CFU) assays, we have revealed that loss
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of Ing4 in mice resulted in a shift in the endogenous HSC sub-populations towards short
term-HSCs (ST-HSCs)/long term-HSCs (LT-HSCs) and skewed HSC differentiation
towards granulocyte-macrophage progenitors (GMPs). Furthermore, when sorted LTHSC, ST-HSC, and MPP cells were transplanted into irradiated mice, Ing4-/- LT HSCs
failed to reconstitute recipient BM, while Ing4-/- MPPs were greater contributors to
multilineage engraftment compared to WT MPPs. Interestingly, MPPs are a population
that have lost the self-renewal capacity of a stem cell, but our data suggests that under stress
hematopoiesis, the loss of Ing4 likely results in reprogramming of MPPs to gain stem-like
features. Further characterization of this HSC sub-population is underway. Moreover, the
inability of Ing4-/- LT HSCs to engraft suggests an evolutionary requirement for Ing4 in
normal hematopoiesis and gives us insight into how Ing4 modulates inflammatory
pathways to regulate HSC function.
Through a number of in situ hybridization studies, we have previously shown that
Ing4-deficient zebrafish embryos have decreased expression of HSC specific genes, runx1
and c-myb, in the aorta—gonad—mesonephros (AGM) region, while mRNA based
overexpression of human ING4 results in increased expression of these same genes,
suggesting that normal expression levels of Ing4 are required for HSC specification. As in
mice, Ing4 deficiency in zebrafish results in increased expression of NF-kB target genes.
Interestingly, simultaneous inhibition of NF-kB and Ing4 restores HSC formation in
embryonic zebrafish. Based on these observed effects and the literature published on our
mouse model, we conducted a mini screen of NF-kB inhibitors with known modes of
action, to identify those that could compensate for the consequences of Ing4 loss of
function. These experiments revealed that NF-kB inhibitors, MRT673007, Senexin, and
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Parthenolide significantly reduced cytokine expression in Ing4-deficient zebrafish and as
expected, rescued HSC specification in this system.
Our findings support a novel role for Ing4 in blood development and highlight a
potential molecular mechanism by which Ing4 regulates hematopoiesis through the NF-κB
pathway. This provides further insight into the characterization of factors and pathways
involved in hematopoiesis and the specific genetic defects in these regulators that can be
targeted for therapeutic treatment of blood disorders.
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CHAPTER 1
INTRODUCTION
Hematopoiesis is a tightly regulated process that relies on a complex network of
regulatory mechanisms to establish the blood system. Essential to this program are
hematopoietic stem cells (HSCs), which differentiate to produce a series of progenitor and
precursor populations, ultimately giving rise to all mature hematopoietic lineages
throughout the lifetime of an organism. Various cells produced through hematopoiesis
perform a multitude of roles for the body. Red blood cells oxygenate the entire body
system, myeloid-derived and lymphoid-derived white blood cells provide host defense
mechanisms through the innate and adaptive immune responses, and platelets promote
blood clotting and tissue repair following vessel injury. The hematopoietic compartment
must maintain homeostasis and promote these processes when needed, thus preserving a
careful balance between HSC maintenance and differentiation under steady-state
conditions. A hallmark of HSCs is their ability to differentiate and self-renew due in part
to the interworking of transcription factors and chromatin remodeling enzymes that activate
or inhibit target gene expression. These factors provide an entry point for clarifying how
HSCs develop during embryogenesis and how specification is programmed (Hsia et al.,
2005).
To uncover chromatin factors that are necessary for the establishment of HSCs, we
conducted the first large-scale in vivo reverse genetic morpholino-based screen targeting
zebrafish orthologues of 425 human chromatin factors (Huang et al., 2013). In this study,
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over a dozen chromatin remodeling factors, with no previously known association to HSCs,
were found to be involved in blood formation, including the histone acetylation complex,
Hbo1. (Fig. 1.1.) This complex functions to promote gene expression through the binding
of H3K4me3 by inhibitor of growth 4 (Ing4), which results in localized Hbo1 histone
acetylation (Coles et al. 2009)(Orkin, 2008). Ing4, a member of the inhibitor of growth
(ING) family, has been suggested to regulate a wide variety of cellular processes, including
DNA repair, apoptosis, cell-cycle regulation, metastasis, angiogenesis, and tumor
suppression (Li et al., 2015) (Coles et al., 2010). While no role for Ing4 has been
established in HSCs, we have previously shown, through a number of in situ hybridization
studies, that Ing4-deficient zebrafish embryos have decreased expression of HSC specific
genes, runx1 and c-myb, while mRNA based overexpression of human ING4 results in
increase expression of these same genes (Fig. 1.2.). This suggests that normal expression
levels of Ing4 are required for HSC specification.
The extent of altered hematopoiesis upon the loss of Ing4 expression in HSCs,
however, has not yet been tested. Our lab is particularly interested in understanding how
Ing4 affects the development of stem and progenitor cells and cell lineage fate. The body
of literature presented here will highlight what is known about the interrelation of
transcriptional regulators and inflammation, thus providing the framework for our studies
on elucidating the role of Ing4 in hematopoiesis and the onset of human disease.
1.1. Transcriptional Regulation of Hematopoiesis
Blood production is a dynamic process that happens in two waves during
development: the primitive and the definitive wave.
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Figure 1.1. Protein interaction network of genes involved in hematopoietic cell
development. Screen identified several genes and chromatin factors involved in
hematopoiesis. Each module is assigned a unique color, and those that share the same
chromatin function are highlighted in the same background color. Grey circles represent
chromatin factors that not associated with isolated complexes.

Figure 1.2. Normal expression levels of Ing4 are required for HSC specification.
From left to right, wild-type zebrafish with observable expression of HSC markers, runx1
and c-myb in the AGM, Ing4-deficient zebrafish embryos with significantly reduced
expression of HSC markers in the same region and mRNA-based overexpression of
human ING4 in zebrafish, which restored HSC expression.

The primitive wave, which occurs in the mammalian yolk sac (Moore & Metcalf,
1970), is the initial wave of hematopoiesis, that gives rise to erythrocytes and macrophages
during early embryonic development (Palis and Yoder, 2001). The primary purpose of the
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primitive wave is to produce red blood cells that can facilitate tissue oxygenation as the
embryo undergoes rapid growth (Orkin and Zon, 2008). This stage is transient and is later
replaced by the definitive wave. In contrast, the definitive wave begins autonomously in
the aorta–gonad–mesonephros (AGM) region surrounding the dorsal aorta (Medvinsky,
1996, de Bruijn, 2000) to produce smaller erythroblasts that express adult hemoglobin’s
and various other mature blood cells (Chen, 2014). These definitive HSCs then migrate
from the AGM to colonize the fetal liver and ultimately the bone marrow (Takeuchi, 2002).
Multipotent long-term HSCs (LT-HSCs), which are responsible for sustaining and
replenishing the blood system, are generated during this second wave (Müller, 1994).
Targeted disruption of several genes, including the hematopoietic transcription
factors Scl/Tal-1, Lmo2, Gata-1, and Gata-2, diminishes or completely abrogates primitive
hematopoiesis (Silver and Palis, 1997). Scl/Tal-1 (T-cell acute lymphocytic leukemia 1) is
a basic helix-loop-helix transcription factor that forms a DNA-binding complex with Lmo2
(LIM domain only 2) (Nam and Rabbitts, 2006). Loss of function murine models for
Scl/Tal-1 and Lmo2 result in embryonic death due to the absence of primitive
erythropoiesis and myelopoiesis (Shivdasani and Mayer, 1995)(Yamada et al., 1998).
Similarly, Gata-1 and Gata-2 mutant mice die mid-gestation due to arrested development
of embryonic erythrocyte precursors that results in severe anemia (Fujiwara, 1996) (Silver
and Palis, 1997). Both Gata-1 and Gata-2 govern the development of erythrocytes
(Moriguchi, 2014) and megakaryocytes during primitive and definitive hematopoiesis
(Lugus, 2007)(Belele, 2009) and thus are important for HSC regulation.
Gata-1 was the first erythroid master regulator identified and remains the beststudied hematopoietic transcription factor (Cantor & Orkin, 2002)(Welch et al., 2004). By
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contrast, SPI1/PU.1, is the master regulator of myelopoiesis (Scott et al., 1994), which
results in the development of neutrophils, dendritic cells, and monocytes, from a myeloid
progenitor cell. As master regulators, Gata-1 and PU.1 find themselves at odds during
hematopoietic development, mutually inhibiting each other to control cell lineage fate. To
promote erythroid differentiation, Gata-1 binds PU.1’s upstream regulatory element,
consequently repressing PU.1 (Chou et al., 2009) and many of the myelolymphoid
downstream target genes of PU.1 (Wontakal et al., 2012). Previous studies have shown that
forced expression of Gata-1 is sufficient to reprogram myeloid into erythroid cells in both
avian and murine cell lines (Kulessa et al., 1995)(Yamaguci et al., 1998). Conversely,
although PU.1 is highly expressed in myeloid and B-cells, it is also normally present in
immature erythroid progenitors (Back et al., 2004), where it antagonizes erythroid
differentiation by binding to and inhibiting the genes encoding Gata-1 and Scl, and
important Gata-1 cofactors (Wontakal et al., 2012).
In definitive hematopoiesis, runx1 and c-myb have been established as the earliest
markers due to their expression in the AGM during HSC specification (Thompson et al.,
1998)(Kataoka et al., 2000). Runx1, a member of the runt family of transcription factors,
plays an important role in hematopoiesis. Wang et al. demonstrated that loss of runx1 in
mice resulted in embryonic lethality and a block on definitive erythropoiesis and
myelopoiesis (Wang et al., 1996). More recently, runx1 has been shown to be required for
the switch of endothelial cells to hematopoietic progenitor stem cells (HSPCs) (Chen et al.,
2009)(Yzaguirre, 2017). Similarly, c-myb, which belongs to the myb family of protooncogenes (Greco et al., 2001), is a critical transcription factor for definitive
hematopoiesis. c-myb is highly expressed in immature HSCs and its expression is down
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regulated as they become more differentiated (Gonda and Metfcalf, 1984). Soza-Reid et al.
showed that c-myb is dispensable for primitive erythropoiesis in zebrafish even though it
is expressed in these cells (Soza-Ried, 2010). By contrast, c-myb-/- mice died in utero at
E15.5 with severe anemia and displayed defects in erythroid and myeloid development
(Mucenski et al., 1991). Comparatively, c-myb mutant zebrafish survived into early
adulthood, but as seen in the knockout mice, definitive hematopoiesis was permanently
extinguished upon the loss of c-myb (Soza-Ried, 2010). Taken together, due to their roles
in HSC regulation, these transcripts can be widely used in animal knockout models and
cell lines to study developmental hematopoiesis.
1.2. Inflammation and Hematopoiesis
Inflammatory signaling pathways regulate many aspects of hematopoiesis,
including embryonic development, emergency granulopoiesis, and age-associated
hematopoietic defects. Several recent publications have identified new mechanisms for
regulation of inflammatory signaling in HSPCs. Using zebrafish and mouse models, the
Molero laboratory recently reported an evolutionary-conserved signaling pathway linking
inflammasomes with HSPC fate decision, where inflammasomes can refine protein
quantities of the lineage-specific transcription factor, Gata-1 (Trysalka, 2019). Their work
suggests that inflammasomes activate caspases capable of cleaving Gata-1 and inactivating
it, promoting myeloid cell fate at the expense of erythropoiesis.
Skewed differentiation towards the myeloid lineage from HSPCs is a frequent
stress-induced hematopoietic response (Chavakis, Zhao 2015). Cytokines are essential in
regulating hematopoiesis and promoting myeloid-biased differentiation. Previous work on
proinflammatory cytokine TNF-α suggest its complicated role in hematopoiesis (Baldridge
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et al., 2011)(Ishida et al., 2017)(Pearl-Yafe et al., 2010)(Pronk et al., 2011) and essential
function in HSC specification (Espin-Palazon et al., 2018). Recently, the Passegué
laboratory clarified the role of TNF-α in HSCs as a pro-survival and pro-regeneration
factor. TNF-α-induced p65-NF-κB activity protected HSCs from necroptosis-mediated
elimination and triggered a strong regenerative program, resulting in emergency
myelopoiesis via upregulation of lineage-specific transcription factor PU.1 (Yamashita et
al., 2019) Similarly, Etzrodt et al. reported TNF-α as the principal PU.1 inducing signal in
HSCs (Etzrodt et al., 2019) while the chromatin remodeling protein, Phf6, was recently
identified as a modulator of TNF-α signaling (Miyagi et al., 2019).
Inflammatory cues from toll-like receptor (TLR) ligands, interferons (IFNs) and
interleukins (ILs) have also been shown to activate proliferation, differentiation, and HSC
emergence. Using an in vitro model of B cell maturation, Hayashi et al. demonstrated that
TLR4 and TLR2 have distinct effects on B lymphocyte differentiation. While TLR4
signaling favored B lymphocyte maturation, TLR2 arrested the differentiation process
(Hayashi et al., 2005). In a separate study, lymphoid-biased progenitors were directed to a
dendritic cell fate in response to TLR signaling, that suppressed B lymphopoiesis (Nagai
et al., 2006).
In an emerging infectious disease model for human monocytic ehrlichiosis (HME),
IFN-γ signaling resulted in altered myeloid differentiation and changes in hematopoietic
progenitor cell function. By contrast, IFN-γ was dispensable for lymphoid differentiation
during infection (MacNamara et al., 2012). In an in vivo mouse model of Mycobacterium
avium infection, LT-HSCs, which remain mainly quiescent in the BM niche, were found
to be actively cycling in response to IFNγ stimulation during chronic infection. This
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resulted in rapid expansion of downstream progenitors to restore and maintain homeostasis
during inflammatory stress. The effects of this response on LT-HSCs was exhibited by a
transplantation experiment, where LT-HSCs from infected mice failed to regenerate.
Similarly, in response to IFNα treatment, HSCs showed decreased quiescence, as they
exited G0 and entered active cell cycling (Essers et al., 2009).
Historically, interleukins have also been associated with hematopoiesis. In an
earlier study, purified, bacterially synthesized IL-3 was injected intraperitoneally into mice
over the course of six days. This inflammatory stimulus promoted progenitor
differentiation at the expense of self-renewal (Metcalf et al., 1986). In a colitis disease
murine model, the loss of quiescence in LT-HSCs, skewed progenitor activity, and other
changes in the HSPC compartments, were a direct response to IL-23-driven-inflammation
(Griseri et al., 2012). Using zebrafish models of IL-6 pathway deficiencies, Tie et al.
showed the necessity of IL-6 signaling for embryonic HSC specification. Myeloid cells
from both the early primitive wave of hematopoiesis and the later definitive erythromyeloid progenitors (EMPs) were revealed as major sources of IL-6 (Tie et al., 2019).
These studies demonstrate the impact of cytokines in regulating hematopoiesis and suggest
the potential unintended consequences to the hematopoietic system associated with the use
of cytokine inhibitors in treating inflammatory diseases.
HSCs must maintain a balancing act between two inflammatory signaling extremes.
On one hand, fully activated HSCs expressing little NF-κB have low regeneration potential
(Yamashita et al., 2019); conversely, increased NF-κB activity is associated with decreased
quiescence, rapid expansion of progenitor cells, and impaired long-term engraftment upon
transplantation (Weisser et al., 2016)(Nakagawa et al., 2018)(Ramalingam et al., 2020).
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Ramalingam et al. showed that sustained inflammation in murine BM adversely impacted
hematopoiesis via chronic activation of endothelial MAPK and NF-κB signaling. Donor
BM cells from a competitive transplant displayed proliferative stress and decreased
functionality. The resulting proinflammatory cytokines expressed in the BM niche drove
myeloid-biased differentiation in HSCs at the expense of self-renewal (Ramalingam et al.,
2020). These studies underscore the versatile role of cytokine signaling and inflammatory
stress in regulating cell fate and hematopoiesis lineage bias.
1.3. Ing4
The founding member of the inhibitor of growth (ING) family, Ing1, was the first
of the ING genes to be characterized using overexpression and antisense knockdown of
Ing1 normal human diploid fibroblasts (Garkavtsev et al., 1996). It was found that ectopic
overexpression of Ing1 blocked cell cycle progression, while inactivation in cell lines,
resulted in malignant cell transformation (Garkavstev et al., 1996). Garkavstev et al. also
highlighted a novel role of Ing1 as a transcription regulator of tumor suppressor, p53, as
functional loss of either of these genes, prevented their ability to inhibit cellular growth
(Garkavtsev et al., 1998). This study indicated Ing1 as an important component of the p53
signaling pathway. Though Ing1 remains the most widely studied of the Ing proteins,
research has also linked Ing2-5 as regulators of several cellular processes, such as cell cycle
and apoptosis, chromatin remodeling, and inflammation (Nagashima, 2003)(Doyon, 2006)
(Shen et al., 2007) (Kumamoto et al., 2010).
Ing proteins contain highly conserved plant homeodomain (PHD) zinc fingers, a
common characteristic for chromatin-modifying nuclear proteins (Kalkhoven, 2002). In
particular, the PHD fingers of the Ing proteins specifically bind to H3K4me2 and
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H3K4me3 (Pena, 2006), which supports the role of Ing family members as chromatin
remodeling proteins and transcription factors. Our protein of interest, Ing4, is a key subunit
of the histone acetylation complex, HBO1-JADE-hEAF6, responsible for the majority of
histone H4 acetylation in eukaryotes (Doyon, 2006). Ing4 is required for efficient
chromatin modification by Hbo1, as depletion of Ing4, greatly reduces the ability of this
complex to acetylate nucleosomal histones (Doyon, 2006), and thus affecting gene
expression. Moreover, Ing4 is often mutated in various human cancer cell lines (Kim,
2004) and in brain (Garkavstev, 2004), breast (Keenan, 2016), and colon (Chen et al., 2016)
cancers, where Ing4-deficiency is associated with poor prognosis due to aberrant cell
proliferation. On the other hand, overexpression of Ing4 results in decreased S-phase
cellular activity (Shiseki, 2003) (Li et al., 2015). Therefore, in cancers, Ing4 expression is
inversely correlated with cell cycle progression.
Ing4 is among the few known regulatory proteins that can directly interact with
chromatin as well as with transcription factors, including p53, NF-κB and HIF-1α.
Overexpression of Ing4 results in p53-dependent apoptosis in a human colorectal cell line
(Shiseki, 2003) and reduction of p53 expression in osteosarcoma cells (Li et al., 2015).
Ozer et al. demonstrated that presence of Ing4, suppressed expression of HIF-1α target
genes under hypoxic conditions. Ing4 does not bind directly to HIF-1α but instead to HPH2, a regulator of HIF-1α stability (Ozer et al., 2005). As part of the Hbo1 complex, Ing4
sequesters RelA/p65, the large subunit of the NF-kB protein complex, in the cytoplasm
thus resulting in suppression of NF-κB target genes (Coles, 2010). The extent of altered
NF-kB signaling upon the loss of Ing4 was furthered demonstrated by Nozell et al. In
human gliomas, absence of Ing4 resulted in higher levels of NF-κB and its target genes,
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MMP-9 and COX-2 (Nozell et al., 2008). Similarly, in an Ing4-deficient mouse model, loss
of Ing4 caused hyper inflammatory responses to LPS, a known activator of NF-κB
signaling. The aberrant activation of NF-κB, and subsequent overexpression of some NFκB target genes, is attributed to the loss of signaling regulation by Ing4 (Coles, 2010)( Fig.
1.3.). These mice are developmentally normal. They display elevated cytokine responses
but fail to develop spontaneous tumor, suggesting Ing4 deficiency itself may not be
sufficient so initiate tumorigenesis (Coles et al., 2008)(Du et al., 2019).

Figure 1.3. Schematic diagram for the role of Ing4 in regulation of IkB expression
and NF-κB activity. Up-regulation of nuclear NF-κB by LPS treatment leads to
increased RelA-responsive promoter activation and cytokine production in Ing4
transgenic mice. Figure adapted from Coles, A. H., Gannon, H., Cerny, A., Kurt-Jones,
E., & Jones, S. N. (2010). Inhibitor of growth-4 promotes IkB promoter activation to
suppress NF-kB signaling and innate immunity.
As in mice, Ing4 deficiency in zebrafish results in increased expression of NF-κB
target genes. We have previously shown that simultaneous inhibition of NF-κB and Ing4
restores HSC formation in embryonic zebrafish (Fig. 1.4.). Based on these observed effects
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and the literature published on our mouse model, we conducted a mini screen of NF-κB
inhibitors with known modes of action, to identify those that could compensate for the
consequences of Ing4 loss of function. The zebrafish is a desirable model system due to
their high fecundity, rapid development, evolutionary conservation, and ease in generating
genetic knockdowns (Huang et al., 2013). We generated an Ing4 knockdown zebrafish
model by designing an anti-sense morpholino oligo against Ing4 and injecting it into
zebrafish embryos at the single cell stage.

Figure 1.4. Rescue of HSC specification due to Ing4 inactivation through inhibition
of NF-kB. HSC marker expression, runx1 and c-myb, in the AGM region is shown. A
uninjected wildtype, B ing4 morphant, C RelA/p65 morphant, D ing4 and RelA/p65
double morphant.
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We propose that Ing4 is required for HSC gene regulation to direct both stem cell
maintenance and differentiation. Utilizing Ing4-deficient mouse and zebrafish model
systems, our work aims to establish Ing4 as a critical regulator of HSC specification
through in vivo and in vitro experiments and highlight a potential molecular mechanism
by which Ing4 regulates hematopoiesis through the NF-κB pathway.
This data will broaden our understanding on the basic biology of HSCs and the
relationship between inflammatory pathways and hematopoietic development, which could
lead to improved therapeutic treatments for blood disorders and Ing4-deficient cancers and
become helpful for marrow and cord blood transplantation.
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CHAPTER 2
MATERIALS AND METHODS
Mice
C57BL/6J (CD45.2) and B6.SJL-PtpcraPepcb/BoyJ (CD45.1) were purchased from
the Jackson Laboratory (Bar Harbor, ME). Ing4 knockout mice (C57BL/6 background)
were obtained from Stephen Jones at the University of Massachusetts Medical School
(Coles, 2010). Ing4 knockout mice were bred and maintained on a C57BL/6J (CD45.2)
genetic background. Six- to 12-week old mice were used as donors for transplantation
assays and eight- to 12-week old mice were used as recipients. Similarly, six- to 12-week
old mice were used for in vitro experiments. Respective littermates or aged-matched WT
animals were used as controls and as competitive donors. All mice were housed in a barrier
unit maintained in The Department of Laboratory Animal Resources (DLAR) at the
University of South Carolina. Specifically, immunocompromised recipient mice (CD45.1)
were housed in sterile conditions for two weeks following transplantation. These mice were
maintained on water supplemented with Baytril (0.01 mg/mL) and sterilized food. All
experiments were done in accordance with the Association for Assessment and
Accreditation of Laboratory Animal Care (AAALAC) and National Institute of Health
(NIH) Office of Laboratory Animal Welfare (OLAW) guidelines and under the protocols
approved by Institutional Animal Care and Use Committee (IACUC) at the University of
South Carolina.
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Zebrafish
Zebrafish (Danio rerio) Tübingen strain were bred and maintained in accordance
with the Association for Assessment and Accreditation of Laboratory Animal Care
(AAALAC) and National Institute of Health (NIH) Office of Laboratory Animal Welfare
(OLAW) guidelines and under the protocols approved by Institutional Animal Care and
Use Committee (IACUC) at the University of South Carolina. Zebrafish were bred and
embryos were collected for microinjection within 45minutes post fertilization. Ing4
antisense oligo morpholino microinjections were performed at the 1-2 cell stage. Injection
volumes were measured using a stage micrometer and injected once into the yolk of the
embryo. Post microinjection, embryos were raised to 24 hpf in 100mm Petri dishes at a
density of 100 embryos or less per dish. Ing4-morphant and control embryos were
dechorionated and treated with DMSO, 5μM MRT67307, 10μM Senexin, or 2μM
Parthenolide. in 96-well plate format with 5-7 embryos per well.
Ing4 Morpholino Design and Synthesis
Ing4 sequence was analyzed to identify most suitable target sites for morpholino
knockdown. Translation blocking, or ATG, morpholinos were designed if the
transcriptional start site was well annotated. Target regions fall within a 25 base pair range
surrounding the ATG site. Once the target site was selected, DNA sequences were
submitted for morpholino oligonucleotide design and synthesis (Gene-Tools). To prepare
morpholinos for injection, lyophilized morpholinos were dissolved in nuclease-free water
to a stock concentration of 2mM and stored at room temperature. Before microinjection,
morpholinos were diluted to the appropriate concentration and heated for 5 min at 65 C to
minimize secondary structures.
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In-situ hybridization
Zebrafish embryos were dechorionated by hand or using pronase and fixed in 4%
paraformaldehyde at 4o Celsius. Embryos 24hpf and older were bleached to remove
pigmentation, then dehydrated in methanol and stored at -20o Celsius. Complementary
DNA probes were synthesized from restriction enzyme linearized plasmid and transcribed
with T7, SP6, or T3 polymerase in the presence of RNA DIG labelling mix to generate
probes according to manufacturer’s protocol (Qiagen). When the embryos reached 36hpf,
they were harvested and subjected to in situ hybridization using probes against c-myb and
runx1 expression, two HSC specific markers.
RT-PCR
Treated and control embryos were collected in Trizol (Invitrogen) and
homogenized using a homogenizer. RNA was extracted according to the Cold Harbor
Spring Protocol (Lan et al., 2009). For reverse transcription reactions, 1 μg of total RNA
was used. cDNA was synthesized using Superscript III First Strand Synthesis SuperMix
for qRT-PCR kit (Invitrogen) according to the manufacturer’s instructions. All genespecific primers used are listed below. gapdh was used as the housekeeping gene.
Colony Forming Unit Assays
Colony-forming units (CFUs) in methylcellulose were quantified to assess
hematopoietic progenitor activity. All cultures were performed at 37oC in a 5% CO2 water
jacket incubator (Thermo Scientific). Whole bone marrow (WBM) was isolated from
femurs by gently crushing with a mortar and pestle, washed with cold mouse buffer (2.5%
FBS, 1% Pen-strep, 1x PBS) and filtered over a 40 μm filter (Fisher) to obtain single-cell
suspension.
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Table 2.1. Primers for small molecule screen. Following pharmacological inhibition of
NF-kB, we used the following primers to detect cytokine expression in WT and Ing4
morphant zebrafish.

zIL6F– TCAACTTCTCCAGCGTGATG

IL-1b

zIL6R– TCTTTCCCTCTTTTCCTCCTG

zIL2RgaF– TCAGGGCTCGGATAACCTA

IL-2R

zIL2RgaR– CGTCACAGACATGGAACCCA

zIL62F– AGACCGCTGCCTGTCTAAAA

IL-6

zIL62R– CAACTTCTCCAGCGTGATGA

zIL42KKF– GCAGCATATACCGGGACTGG

IL-4

zIL42KKR– ATGGCAGCATGCTTTGGTTT

zGapdhF- GTGGAGTCTACTGGTGTCTTC
Gapdh
zGapdhR- GTGCAGGAGGCATTGCTTACA

Viable cell counts were determined with a hemocytometer using Trypan Blue (Life
Technologies). WT and Ing4-/- WBM cells (1x104 cells/well) were plated in triplicate into
a six-well plate containing Methocult GF M3434 methylcellulose (StemCell Technologies)
according to the manufacturer’s suggestions. Colonies were scored after 10 days for
phenotypic CFU-GEMM, CFU-GM, CFU-M, CFU-G, and BFU-E colonies using a Motic
Swift Line AE31R inverted microscope (Fisher). This experiment was repeated five times
under the same conditions.
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Competitive Transplantation
Adult CD45.1 recipient mice (n= 20) were pre-conditioned with lethal irradiation
(9.5 Gy) in a split dose prior to transplantation. WBM was isolated from femurs by gently
crushing with a mortar and pestle, washed with cold mouse buffer (2.5% FBS, 1% Penstrep, 1x PBS) and filtered through a 40 μm filter (Fisher). Viable cell counts were
determined with a hemocytometer using Trypan Blue (Life Technologies). After
processing the sample, 1x105 WT or Ing4-/- WBM cells (CD45.2) were transplanted with
4x105 competitor WBM cells (CD45.1) via retro-orbital injections into irradiated recipient
(CD45.1) mice. For sorted transplant, adult CD45.1 recipient mice (n= 60) were preconditioned with lethal irradiation (9.5 Gy) in a split dose prior to transplantation. After
processing the sample as aforementioned, 10 LT-HSCs, 50 ST-HSCs, and 100 MPPs WT
or Ing4-/- WBM cells (CD45.2) were transplanted with 2x105 competitor WBM cells
(CD45.1) via retro-orbital injections into irradiated recipient (CD45.1) mice. Retro-orbital
bleeds using 75mm heparinized glass capillary tubes (Fisher) were used to assess
multilineage hematopoietic engraftment at four weeks, 12 weeks 16 weeks, and a year posttransplantation. Prior to staining for flow cytometry, peripheral blood (PB) was spun for
seven minutes at 1200rpm, resuspended in 1X Red Blood Cell (RBC) lysis buffer
(Miltenyi) then washed with cold mouse buffer (2.5% FBS, 1% Pen-strep, 1x PBS). Cell
populations were stained and analyzed using flow cytometry.
Progenitor Activity
To further characterize the hematopoietic progenitor population in the murine bone
marrow, femurs were gently crushed with a mortar and pestle, washed with cold mouse
buffer (2.5% FBS, 1% Pen-strep, 1x PBS) and filtered through a 40 μm filter (Fisher) to
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obtain a single cell suspension. For optimal flow cytometry immunophenotyping, RBC
were removed from the samples using 1x RBC lysis buffer (Miltenyi). Additionally, viable
cell counts were determined with a hemocytometer using Trypan Blue (Life Technologies)
for subsequent enrichment of lineage negative (Lin-) cells using the Direct Lineage Cell
Depletion Kit (Miltenyi). For depletion, cells were magnetically labeled with a cocktail of
microbeads conjugated to antibodies against lineage markers (CD5, CD45R (B220),
CD11b, Gr-1 (Ly-6G/C), 7-4, and Ter-119) (32). Bead-labeled cells were separated with
manual LS columns according to the manufacturer’s instruction (Miltenyi). The resulting
cell suspension of isolated unlabeled Lin- cells was stained and used for flow cytometry
analysis. This experiment was repeated four times with (n = 3) for each experiment.
Flow cytometry
As described above, HSCs were purified from murine bone marrow and
characterized using phenotypic cell surface markers. Sample data were collected and
analyzed using an LSR II Sorp (BD Biosciences) with FACS Diva (BD Biosciences) and
FlowJo software. Gates were established using unstained controls. The antibody panels
used for immunofluorescence staining for HSC and progenitor isolation were as followed:
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Table 2.2. Flow cytometry stain for chimerism analysis of WBM transplantation. For
transplantation experiments, PB chimerism and multilineage hematopoietic engraftment
of donor-derived cells were assessed. Recipient (CD45.1), donor (CD45.2), competitor
(CD45.1), CD3e (T cells), B220 (B cells), Mac1/CD11b (Macrophages), Ter119
(Erythrocytes), Gr-1 (Granulocytes).

Quantitation and Statistical Analysis
All experiments were repeated as indicated; n indicates the number of biological
replicates. Data are presented as the mean ± standard error of the mean (SEM). Student’s
t-test was used to evaluate statistical comparison between two groups. Statistical
significance was indicated by *(P < 0.05), **(P < 0.01), ***(P < 0.001), and n.s (not
significant.
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Table 2.3. Flow cytometry stain for HSC sorted transplantation assay. Isolation of
donor-derived HSC-subpopulations for sorted transplantation experiments. Lin- fraction:
CD34, CD48, CD150, Sca-1, c-Kit (LSK). Lin+ fraction: Mac1/CD11b (Macrophages),
B220 (B cells), Ter119 (Erythrocytes), Gr-1 (Granulocytes), CD3e (T cells).

21

Table 2.4. Progenitor stain for flow cytometry analysis. BM cells were stained to
characterize the progenitor compartment in WT and Ing4-deficient mice. Lin- fraction:
CD34, CD48, Sca-1, c-Kit (LSK), CD16/32 (myeloid progenitors), CD127 (lymphoid
progenitors). Lin+ fraction: Mac1/CD11b (Macrophages), B220 (B cells), Ter119
(Erythrocytes), Gr-1 (Granulocytes), CD48 (B cells), CD3e (T cells).
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CHAPTER 3
RESULTS
3.1. Loss of Ing4 results in skewed HSC differentiation
The hallmark of HSCs is their ability to differentiate and self-renew. The process
of differentiating from a multipotent stem cell to a lineage-committed cell is tightly
regulated by transcription factors and chromatin remodeling proteins that change gene
expression. To assess the ability of HSCs to proliferate and differentiate in the absence of
Ing4, we cultured WT and Ing4-/- BM cells in methylcellulose and scored colony
phenotypes at 10 days. Marrow collected from mice in steady-state conditions showed that
Ing4 inactivation hindered colony-forming abilities of BM progenitor cells (Fig. 3.1.). This
was reflected in the significant decrease of CFU-M (macrophages) (WT vs. Ing4-/-) (
24.64 vs. 32.16), CFU-GEMM (granulocytes, erythrocytes, megakaryocytes, monocytes)
(2.32 vs. 6.71), and CFU-GM (granulocytes, macrophages) (5.11 vs. 8.72) colonies in the
Ing4 null mice. We found no significant change between the WT and the Ing4-/- CFU-G
and BFU-E colonies.
To determine if loss of Ing4 affected HSC lineage specification, we analyzed the
PB of Ing 4-/- and WT mice in steady-state conditions. As expected, (B220+/CD3+)
progenitor cells had a negligible presence in the PB of recipient mice (Fig. 3.1.). Generally,
these cell populations are found in small numbers circulating in the blood. Similar to the
CFU assays, there was no difference between the WT and Ing4 null populations of mature
erythrocyte (Ter119+) and granulocyte (Gr-1+) cells.
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Figure 3.1. CFU analysis of progenitor activity in mouse BM. Methylcellulose based
progenitor assay from WT and Ing4-deficient BM cells. Bar graphs indicate number of
CFUs per 104 WBM; CFU-G (granulocytes), CFU-M (macrophages), CFU-GEMM
(Granulocyte, erythroid, monocyte, megakaryocyte), CFU-GM (granulocyte,
macrophage), BFU-E (erythroblasts). *P < 0.05; **P <0 .01; ***P < 0.001, nsP> 0.05.
Notably, Ing4-/- PB showed an increase in the frequency of T cells (CD3+) and a
significant decrease in B cells (B220+). This suggests that Ing4 affects HSC
specification. Interestingly, PB showed a significant increase in circulating macrophages
(Mac-1+), compared to the WT, indicating that the absence of Ing4 promotes a myeloidbias in the PB. However, the opposite was observed in the methylcellulose-based colony
assays of BM cells (Fig. 3.2.).
To characterize the progenitor compartment upon Ing4 inactivation, we analyzed
the murine BM niche using flow cytometry. We saw a significant increase in the GMP
(52.2% vs. 42.1%) population in the Ing4-/- marrow. A dramatic decrease in the MEPs
(2.17% vs. 16.8%) and a subtle increase in the CMP (34.2% vs. 33.7%) population. This
indicates that loss of Ing4 drives skewed myelopoiesis (Fig 3.3.). Taken together, these
data demonstrate that there is variability in how Ing4 regulates the ability of progenitor
cells to proliferate and differentiate into lineage committed cells.
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Figure 3.2. Lineage specific cell populations in mouse PB. Flow cytometry analysis of
lineage specific cells in the PB of Ing4-/- and WT mice in steady-state conditions. CD3
(T cells), B220 (B cells), Mac1/CD11b (Macrophages), Ter119 (Erythrocytes), Gr-1
(Granulocytes), LSK (Lin−Sca-1+c-Kit+ ). *P < 0.05; **P <0 .01; ***P < 0.001,
nsP>0.05.

Figure 3.3. Analysis of progenitor populations in the BM niche. Representative contour
plots demonstrating differentiation of WT and Ing4-deficient cells in steady-state
conditions. The myeloid progenitor population can be identified in the Sca- portion of the
LSK stain. This fraction can be further subdivided into common-myeloid progenitor
(CMP) (CD34+CD16/32-), megakaryocyte-erythrocyte progenitor (MEP) (CD34CD16/32-), and granulocyte-macrophage progenitor (GMP) (CD34+CD16/32).
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3.2. The absence of Ing4 disrupts mouse hematopoiesis
A comparison of the HSC-subpopulations present in the BM niche in steady state,
revealed that absence of Ing4 disrupted mouse hematopoiesis by forcing a shift towards
ST-HSC/LT-HSC in the HSPC compartment (Fig. 3.4.). Compared to WT marrow, Ing4deficiency resulted in a dramatic increase of ST-HSCs (31.7% vs. 11.4%) and decrease in
MPPs (19.3% vs. 47.9%). This data demonstrates that Ing4 is required for normal mouse
hematopoiesis.
We next determined if Ing4-/- HSCs maintain the ability to repopulate recipient
mice. Donor chimerism can be determined by flow cytometry analysis of the peripheral
blood and the bone marrow, using cell surface markers that distinguish donor cells from
recipient. Though we observed changes in the progenitor compartment and the distribution
of HSC sub-populations, the competitive WBM transplantation revealed that total
CD45.2+ cell engraftment was similar for Ing4-/- and WT BM cells (Fig. 3.5.) over a period
of three months. Indicating that HSCs lacking Ing4 can still regenerate in the BM niche.
3.3. Ing4 is required for LT-HSC engraftment but not MPP cells
We determined overall short-term and long-term engraftment was similar in Ing4
null and WT recipient. Next, we wanted to examine if the loss of Ing4 would impact the
reconstitution abilities of each HSC-subpopulation, independently. This data would tell us
if Ing4-dependent altered hematopoiesis drives HSCs to rapidly exhaust. In a sorted
competitive transplant, PB analysis indicated functional differences between WT and Ing4
null HSCs (Fig. 3.6.). Ing4-/-LT-HSCs failed to engraft at six months.
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Figure 3.4. Representative contour plots demonstrating HSC sub-populations present
in WT and Ing4-deficient mice. LT-HSC, ST-HSCs, and MPPs were identified using
LSK (Lin-c-Kit+Sca-1+) and SLAM markers. LT-HSCs (CD34-CD150+), ST-HSCs
(CD34+CD150+), and MPPs (CD34+CD150-).

Surprisingly, Ing4 null MPPs were greater contributors to the BM niche (19% vs.
60%), compared to WT MPPs. Moreover, there was no significant difference in the
repopulation of WT vs. Ing4-deficient ST-HSCs. Collectively, these findings support a role
of Ing4 as an evolutionary requirement for engraftment of bona fide LT-HSCs and a
potential transcriptional repressor of MPPs, as Ing4-/-MPPs gained stem-like features (i.e.
ability to self-renew) in order to reconstitute the BM niche in irradiated mice.
3.4. NF-κB inhibitors can rescue loss of HSC specification in zebrafish
As in our mouse model (Coles, 2010) loss of function of Ing4 in zebrafish results
in increased NF-kB genes. We have previously shown that genetic inhibition of NF-kB in
Ing4-deficient zebrafish restores HSC formation (Fig. 3.7.), thus we wanted to confirm if
this was also true for chemical inhibition of NF-kB.
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Figure 3.5. PB %chimerism following WBM competitive transplantation assay. 1x105
WT or Ing4-/- WBM cells (CD45.2) were transplanted with 4x105 competitor WBM cells
(CD45.1) via retro-orbital injections into (n = 20) irradiated recipient (CD45.1) mice. A,
B, C, D Assessment of total CD45.2 short-term engraftment (four weeks) and long-term
engraftment (12 weeks) (n = 20 recipients; n = 5 donors) for two separate experiments. Top
(A,B): 9/24/20, Bottom (C,D): 7/9/19. *P < 0.05; **P <0 .01; ***P < 0.001, nsP> 0.05.

28

Figure 3.6. Sorted competitive repopulation assay assessing total CD45.2 engraftment
of LT-HSCs, ST-HSCs and MPP cells. For sorted transplant, 10 LT-HSCs, 50 ST-HSCs,
and 100 MPPs WT or Ing4-/- WBM cells (CD45.2) were transplanted with 2x105
competitor WBM cells (CD45.1) via retro-orbital injections into (n = 60) irradiated
recipient (CD45.1) mice. Long-term engraftment (6 months). *P < 0.05; **P <0 .01; ***P
< 0.001, nsP> 0.05.
We conducted a mini screen of NF-kB inhibitors with known modes of action, to
identify those that could compensate for the consequences of Ing4 loss of function. These
experiments revealed that NF-kB inhibitor, MRT673007 significantly reduced expression
of cytokines IL-1b, IL-4, IL-6, and IL-2R. While Senexin only reduced the expression of
IL-1b and IL-4 (Fig. 3.8.), and Parthenolide reduced expression of II-1b, IL-4, and IL-6.
All of these drugs have different modes of action. For example, MRT67307 is an IKKε
inhibitor (Hassan, 2016), Senexin inhibits CDK8/19 (Chen, 2017), and Parthenolide is an
IκB inhibitor (Saadane, 2007). All of which target components of the NF-κB pathway. As
hypothesized, in-situ hybridization results demonstrated that NF-kB inhibitors instigated
varying levels of dose-dependent rescue of the HSC marker, runx1, in the AGM of treated
Ing4-/- zebrafish (Fig. 3.9.). Taken together, these data confirm that both genetic and
chemical inhibition of NF-kB can partially rescue the defects caused by Ing4 deficiency in
zebrafish.
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Figure 3.7. Genetic inhibition of Ing4 and NF-kB target gene restores HSCs in the
AGM. HSC marker expression, runx1 and c-myb, in the AGM region of embryonic
zebrafish 36hpf is shown. A uninjected wildtype, B ing4 morphant, C Il-1b morphant, D
ing4 and Il-1b double morphant.
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Figure 3.8. Pilot chemical screen of NF-kB inhibitors, MRT673007, Senexin, and
Parthenolide. Graphical representation of qRT-PCR results from chemical inhibition of
Ing4 is shown. WT and Ing4-deficient zebrafish were chemically treated with NF-kB
inhibitors or DMSO. Gapdh (not pictured) was used as a housekeeping gene. IL-1b, IL-4,
IL-6, and IL-2r are NF-kB target genes upregulated upon the loss of Ing4 in zebrafish. *P
< 0.05; **P <0 .01; ***P < 0.001, nsP> 0.05.

Figure 3.9. Whole mount in-situ hybridization results of screen for small molecules
that restore HSC specification. Expression of HSC marker, runx1, in the AGM region of
zebrafish embryos is shown. A) WT zebrafish treated with 0.1% DMSO control. B) Ing4
MO zebrafish treated with 0.1% DMSO. C) Ing4 MO zebrafish treated with MRT67307.
Arrows indicate HSC marker staining.
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CHAPTER 4
DISCUSSION
Hematopoietic stem cells are central to the blood program. Their unique ability to
self-renew and differentiate into multipotent progenitor cells, gives rise to all the distinct
blood lineages in a hierarchical manner, while maintaining homeostasis throughout an
organism’s life. This process is under the control of cell-specific transcription factors and
chromatin remodeling proteins that regulate gene expression and consequently, stem cell
fate. We previously have found that normal expression levels of Ing4 are required for HSC
specification in zebrafish (Fig. 1.2.). However, the role of Ing4 in hematopoiesis has not
yet been established.
In this study, we demonstrate Ing4 is critical in HSC self-renewal and
differentiation. First, we analyzed the bone marrow and peripheral blood of Ing4-deficient
and WT mice using CFU assays and flow cytometry in steady-state conditions. Using
methylcellulose-based experiments gives us information about the ability of individual
hematopoietic progenitor cells to proliferate and differentiate into a colony of lineage
committed cells. Similarly, immunophenotyping via flow cytometry, identifies what
lineages are present in mouse PB. In the CFU assays, it was observed that CFU-M
(macrophage), CFU-GEMM (granulocyte, erythrocyte, monocyte, megakaryocyte), and
CFU-GM (granulocyte, macrophage) colonies were significantly decreased in Ing4-/- BM
cells (Fig. 3.1.). Contrastingly, in the PB of Ing4-/- mice, there was an increase in
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macrophages (Fig. 3.2.). The differences we examined in the PB and the marrow can be
explained by the nature of our model system. According to literature published on our
Ing4-/- mouse model, these mice are hyper responsive to LPS treatment, a known activator
of NF-κB signaling. It is likely that we see more macrophages circulating in the PB in these
mice because of the activated inflammatory signaling upon the loss of Ing4. To explore
this further, flow cytometry analysis of HSC lineage specification in the mouse BM will
have to be done.
In addition, we sought to examine if there were changes in the progenitor
compartment when Ing4 is inactivated. Compared to the WT, Ing4-deficient mice showed
enhanced frequency of GMPs (granulocyte/macrophage progenitors) (Fig. 3.3.). This was
interesting since we previously observed a decrease in macrophages in CFU assays. It is
possible that the absence of Ing4 causes progenitor cells to become more quiescent or
“stuck,” thus losing the ability to efficiently differentiate into their lineage specific cells.
Miyai et al. demonstrated that inactivation of early genes Nr4a2, Klf4, and Egr1 in B-cell
progenitors, led to the disruption of their genetic program and loss of B-cell identity (Miyai
et al., 2018). Mature blood cells arise from pluripotent stem cells through a series of lineage
restriction steps; therefore, it is likely that the absence of Ing4, a chromatin remodeling
protein and transcription regulator, leads to inhibition of genes involved in transcriptional
priming of GMPs.
Notably, both MEPs (megakaryocyte/erythroid progenitors) and CFU-GEMMs
were decreased in Ing4-/- mice (Fig. 3.3.) (Fig. 3.1.). Since there was no significant
difference between the erythrocytes in WT and Ing4-/-, we hypothesize that the myeloidlineage cells contributing to this phenotype are megakaryocytes (Mk). Currently, the
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antibody panels we use for immunofluorescence staining of HSPCs does not stain for Mks.
In addition, a shortcoming of CFU assays using Methocult medium is that CFU-Mks can
be difficult to distinguish morphologically from other cell lineages, such as macrophages
(Nikougoftar, 2011). For further analysis, we will have to stain for Mk surface markers and
determine what the distribution of this population is within the Ing4-deficient BM niche,
in conjunction with a Megacult-C assay, which is a collagen-based system that optimally
detects CFU-Mk progenitor cells in human and mouse samples. Taken together, these
experiments elucidate that Ing4 regulates HSC specification and loss of function of Ing4
results in skewed differentiation.
In trying to uncover if Ing4 is a requirement for hematopoiesis, we evaluated HSC
activity through WBM competitive transplantation assays in mice. We hypothesized that
Ing4-deficient HSCs would rapidly lose quiescence and transiently repopulate recipient
mice in response to enhanced stress. The efficacy of bone marrow reconstitution is
determined in the PB output. Conversely, analysis of the PB of recipient mice, revealed
similar short-term and long-term engraftment of WT and Ing4-/- donor-derived cells. This
was interesting, as Ramalingam et al. demonstrated that chronic inflammation, via
activation of NF-κB, resulted in poor long-term engraftment (Ramalingam, 2020). These
results not only support a functional role for Ing4 in normal hematopoiesis, but they
highlight the complex relationship between Ing4 and NF-κB and the possibility of other
signaling pathways regulating hematopoiesis through their interaction with Ing4.
In addition, examination of the HSC-subpopulations in murine BM, revealed a shift
towards LT-HSC/ST-HSCs and a drastic decrease in the MPP compartment (Fig. 3.4.) in
the Ing4 null mice. To determine if the HSC-subpopulations maintained function, such as
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reconstitution potential, we sorted mouse bone marrow into LT-HSCs, ST-HSCs and MPPs
then transplanted the sorted cells into irradiated mice. Interestingly, compared to the WT,
Ing4-/-LT HSCs failed to engraft, while Ing4-/-MPPs showed dramatic increase in
peripheral blood multilineage chimerism up to 9 months post-transplantation (Fig. 3.6.).
Though HSCs remain mainly dormant in the BM niche, they become activated in response
to BM injury or inflammatory stimulation (Wilson et al., 2008) in order to self-renew and
regenerate the blood system. Therefore, the inability of donor-derived Ing4-/-LT-HSCs to
engraft long-term, indicates an evolutionary conserved requirement of Ing4 in self-renewal
and differentiation of bona fide LT-HSCs and subsequently, their ability to reconstitute the
marrow. In this context, Ing4-deficient LT-HSCs are either actively cycling thus rapidly
exhausting due to increased inflammation or they are more quiescent, resulting in slower
HSC expansion. Future cell cycle analysis can further elucidate this HSC activity.
Based on the engraftment ability of Ing4-/-MPPs in the BM, we hypothesize that
Ing4 normally functions as a critical suppressor for genes required for self-renewal and
developmental potency in MPPs, thus the absence of Ing4 results in reprogramming of
MPPs to act like stem-cells. This is an exciting finding as MPPs are a cell population that
have lost the self-renewal capacity of HSCs (Morrison et al., 1994). Moreover, it has been
shown that there is heterogeneity within the MPP compartment. Pietras et al. demonstrated
that this population is composed of distinct lineage biased MPPs that are produced in
parallel by HSCs, but with different kinetics and at variable levels depending on the
demands of hematopoiesis (Pietras et al., 2016). Given this, further characterization of
Ing4-/- MPP cells is underway to determine which subset is contributing to the enhanced
regeneration abilities observed in transplantations.
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As previously mentioned, HSCs must find a careful balance between two inflammatory
signaling extremes. Enhanced NF-κB activity is associated with decreased quiescence,
rapid expansion of progenitor cells, and impaired long-term engraftment upon
transplantation (Weisser et al., 2016) (Nakagawa et al., 2018) (Ramalingam et al., 2020).
While fully activated HSCs expressing little NF-κB have low regeneration potential
(Yamashita et al., 2019). Similar to our mouse model, we have generated an Ing4
morpholino zebrafish model that exhibits an inflammatory phenotype. Evident by the
increase in relative expression of cytokines, IL-1b, IL-4, IL-6, and IL-2R. Specifically, our
data shows that chemical inhibition of NF-κB in Ing4-deficient zebrafish, reduces cytokine
expression and restores HSC specification in the AGM (Fig. 3.8.) (Fig. 3.9.). This
correlates with what we have seen when genetically inhibiting NF-κB in this same model
system (Fig. 3.7.). Overall, these results demonstrate that Ing4 regulates hematopoiesis
through suppression of NF-κB, elucidating a molecular mechanism by which it functions
during HSC specification. A major challenge for cancer researchers and clinicians is how
to identify those patients that are most likely to benefit from NF-κB inhibitors in cancer
therapy, thus the expansion of this pilot assay to examine various other targets and their
ability to restore HSC specification, is promising for the treatment of Ing4-deficient cancers
and hematological disorders.
To gain a better understanding of the molecular changes upon losing Ing4, RNA seq is
a useful tool. By harvesting bone marrow and sorting the HSC-sub populations, this method
would reveal genes that are upregulated/downregulated when Ing4 is inactivated. We
expect to see an increase in some NF-κB target genes since loss of Ing4 causes hyper
response of the innate immune system, but also a decrease in others because a subset is
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regulated by H4 acetylation. We also expect an observed difference in expression of tumor
suppressors such as p53, as Ing4 has been shown to complex with p53 and induce apoptosis
(Shiseki, 2003), along with HIF-1α related genes. Ing4 is upstream of several known
signaling pathways but we anticipate that RNA seq results will elucidate new pathways deregulated by Ing4-deficiency.
In summary, our was aim was to define the role of Ing4 in developmental hematopoiesis
in HSCs by examining the effects of Ing4 inactivation in mice in-vitro and in-vivo. The
clinical importance of HSCs in marrow transplantations for the treatment of bone marrow
failure, cancers, and autoimmune disorders, highlights the significance of understanding
the mechanisms that regulate HSC function and their ability to engraft. Our research
delineates the scope of altered hematopoiesis upon the loss of Ing4, lending us a blueprint
for how this complex system is regulated and how it can be better targeted to improve stem
cell function for therapeutic treatments.
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